BfArM - Federal Institute for Drugs and Medical Devices

Dear Doctor Letter (Rote-Hand-Brief) on Fentanyl^®-Janssen and Durogesic^® SMAT (12, 25, 50, 75, 100 µg/h), transdermal patch (active substance: fentanyl): New warning

2013.03.11

Active substance: fentanyl

New warning regarding medicinal products (and generics) containing fentanyl and the possible occurrence of serotonin syndrome if used concomitantly with serotonergic medicines.

Rote-Hand-Brief on Fentanyl^®-Janssen PDF, 430KB, File is accessible

Rote-Hand-Brief on Durogesic^®SMAT PDF, 392KB, File is accessible

BfArM - Federal Institute for Drugs and Medical Devices

Navigation and service

Dear Doctor Letter (Rote-Hand-Brief) on Fentanyl^®-Janssen and Durogesic^® SMAT (12, 25, 50, 75, 100 µg/h), transdermal patch (active substance: fentanyl): New warning

Contact

Social media

Unternavigation aller Website-Bereiche

Fast Accesses

BfArM - Federal Institute for Drugs and Medical Devices

Dear Doctor Letter (Rote-Hand-Brief) on Fentanyl®-Janssen and Durogesic® SMAT (12, 25, 50, 75, 100 µg/h), transdermal patch (active substance: fentanyl): New warning

Photo credits

Contact

Social media

Dear Doctor Letter (Rote-Hand-Brief) on Fentanyl^®-Janssen and Durogesic^® SMAT (12, 25, 50, 75, 100 µg/h), transdermal patch (active substance: fentanyl): New warning